Genmab A/S (GMAB) Reports FY EPS of $15.37

Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.

For earnings history and earnings-related data on Genmab A/S (GMAB) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Vistra prices $1.5B junior subordinated notes offering due 2057
• Adobe (ADBE) PT Lowered to $315 at JPMorgan